“Gallic Acid: A Potential Therapeutic Agent for Managing Diabetes-Associated Neuroinflammation and Cognitive Decline”, Nig. J. Neurosci., vol. 16, no. 1, pp. 1–8, Apr. 2025, doi: 10.47081/njn2025.16.1/001.